These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16516089)

  • 1. Dobutamine stress echocardiography in patients with diabetes mellitus: enhanced prognostic prediction using a simple risk score.
    Chaowalit N; Arruda AL; McCully RB; Bailey KR; Pellikka PA
    J Am Coll Cardiol; 2006 Mar; 47(5):1029-36. PubMed ID: 16516089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term (>10 Years) Prognostic Value of Dobutamine Stress Echocardiography in a High-Risk Cohort.
    van der Sijde JN; Boiten HJ; van Domburg RT; Schinkel AF
    Am J Cardiol; 2016 Apr; 117(7):1078-83. PubMed ID: 26839054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of dobutamine stress echocardiography in patients with systemic hypertension and known or suspected coronary artery disease.
    Sozzi FB; Elhendy A; Rizzello V; van Domburg RT; Kertai M; Vourvouri E; Schinkel AF; Bax JJ; Roelandt JR; Poldermans D
    Am J Cardiol; 2004 Sep; 94(6):733-9. PubMed ID: 15374776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of left ventricular function during contrast-enhanced dobutamine stress echocardiography predicts future cardiac events in diabetic patients.
    Wake R; Takeuchi M; Yoshiyama M; Yoshikawa J
    Circ J; 2006 Jul; 70(7):868-74. PubMed ID: 16799240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of ankle-brachial index and dobutamine stress echocardiography for cardiovascular morbidity and all-cause mortality in patients with peripheral arterial disease.
    Thatipelli MR; Pellikka PA; McBane RD; Rooke TW; Rosales GA; Hodge D; Herges RM; Wysokinski WE
    J Vasc Surg; 2007 Jul; 46(1):62-70; discussion 70. PubMed ID: 17583463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria.
    Cortigiani L; Rigo F; Gherardi S; Sicari R; Galderisi M; Bovenzi F; Picano E
    J Am Coll Cardiol; 2007 Oct; 50(14):1354-61. PubMed ID: 17903635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of diabetes mellitus on the prognostic value of a normal dobutamine stress echocardiogram in patients with intermediate to high cardiovascular risk.
    Low AF; Ng WL; Lim YT; Yeo TC
    Singapore Med J; 2004 Apr; 45(4):161-5. PubMed ID: 15094984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of akinesis becoming dyskinesis during dobutamine stress echocardiography.
    Sozzi FB; Elhendy A; Rizzello V; Biagini E; van Domburg RT; Vourvouri EC; Schinkel AF; Danzi GB; Bax JJ; Poldermans D
    J Am Soc Echocardiogr; 2007 Mar; 20(3):257-61. PubMed ID: 17336751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of dipyridamole or dobutamine stress echocardiography for evaluation of patients > or =65 years of age with known or suspected coronary heart disease.
    Cortigiani L; Bigi R; Sicari R; Landi P; Bovenzi F; Picano E
    Am J Cardiol; 2007 Jun; 99(11):1491-5. PubMed ID: 17531567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of chronotropic response to dobutamine stress echocardiography in patients with peripheral arterial disease.
    Chaowalit N; Maalouf JF; Rooke TW; Barnes ME; Bailey KR; Pellikka PA
    Am J Cardiol; 2004 Dec; 94(12):1523-8. PubMed ID: 15589008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the prognostic value of dobutamine stress echocardiography differ among different age groups?
    Bernheim AM; Kittipovanonth M; Takahashi PY; Gharacholou SM; Scott CG; Pellikka PA
    Am Heart J; 2011 Apr; 161(4):740-5. PubMed ID: 21473974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of echocardiographic calcium score in patients with a clinical indication for stress echocardiography.
    Gaibazzi N; Porter TR; Agricola E; Cioffi G; Mazzone C; Lorenzoni V; Albertini L; Faden G; Chamsi Pasha M; Biabhav B; Regazzoli D; Di Lenarda A; Faggiano P
    JACC Cardiovasc Imaging; 2015 Apr; 8(4):389-396. PubMed ID: 25797119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of gender on prognosis of patients with known or suspected coronary artery disease undergoing contrast-enhanced dobutamine stress echocardiography.
    Wake R; Takeuchi M; Yoshikawa J; Yoshiyama M
    Circ J; 2007 Jul; 71(7):1060-6. PubMed ID: 17587711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of contrast-enhanced dobutamine stress echocardiography in predicting outcome in patients with known or suspected coronary artery disease.
    Wake R; Takeuchi M; Yoshitani H; Miyazaki C; Otani S; Yoshiyama M; Yoshikawa J
    Echocardiography; 2006 Sep; 23(8):642-9. PubMed ID: 16970715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seven-year follow-up after dobutamine stress echocardiography: impact of gender on prognosis.
    Biagini E; Elhendy A; Bax JJ; Rizzello V; Schinkel AF; van Domburg RT; Kertai MD; Krenning BJ; Bountioukos M; Rapezzi C; Branzi A; Simoons ML; Poldermans D
    J Am Coll Cardiol; 2005 Jan; 45(1):93-7. PubMed ID: 15629381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of heart rate reserve versus 85% of age-predicted maximum heart rate as a measure of chronotropic response in patients undergoing dobutamine stress echocardiography.
    Bangalore S; Yao SS; Chaudhry FA
    Am J Cardiol; 2006 Mar; 97(5):742-7. PubMed ID: 16490449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of myocardial ischemia during dobutamine stress echocardiography on cardiac mortality in patients with heart failure secondary to ischemic cardiomyopathy.
    Elhendy A; Sozzi F; van Domburg RT; Bax JJ; Schinkel AF; Roelandt JR; Poldermans D
    Am J Cardiol; 2005 Aug; 96(4):469-73. PubMed ID: 16098295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Stress Echocardiography in Patients With Low-Intermediate or High Short-Term (10 Years) Versus Low (<39%) or High (≥39%) Lifetime Predicted Risk of Cardiovascular Disease According to the American College of Cardiology/American Heart Association 2013 Cardiovascular Risk Calculator.
    Yao SS; Supariwala A; Yao A; Dukkipati SS; Wyne J; Chaudhry FA
    Am J Cardiol; 2015 Sep; 116(5):725-9. PubMed ID: 26138377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dobutamine stress cardiac magnetic resonance versus echocardiography for the assessment of outcome in patients with suspected or known coronary artery disease. Are the two imaging modalities comparable?
    Bikiri E; Mereles D; Voss A; Greiner S; Hess A; Buss SJ; Hofmann NP; Giannitsis E; Katus HA; Korosoglou G
    Int J Cardiol; 2014 Feb; 171(2):153-60. PubMed ID: 24342416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening of silent myocardial ischaemia by dobutamine stress echocardiography among type 2 diabetics at high cardiovascular risk in Senegal].
    Mbaye A; Yaméogo NV; Ndiaye MB; Kane AD; Diack B; Dioum M; Hakim R; Diagne D; Kane M; Diao M; Diallo A; Diop SN; Kane A
    Ann Cardiol Angeiol (Paris); 2011 Apr; 60(2):67-70. PubMed ID: 20708727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.